Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection

Digestive Endoscopy

Volumn 24, Issue 2, 2012, Pages 110-116

  Niimi, Keiko ^a   Fujishiro, Mitsuhiro ^b   Goto, Osamu ^a   Kodashima, Shinya ^c   Minatsuki, Chihiro ^a   Hirayama, Itsuko ^a   Mochizuki, Satoshi ^a   Ono, Satoshi ^a   Yamamichi, Nobutake ^a   Kakushima, Naomi ^d   Ichinose, Masao ^e   Koike, Kazuhiko ^a  

^a Department of Gastroenterology ^*  (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

endoscopic submucosal dissection; gastric intraepithelial neoplasm; postoperative bleeding; proton pump inhibitor; ulcer healing

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADENOMA; ADULT; AGED; ARTICLE; CLINICAL TRIAL; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH ULCER; TREATMENT RESPONSE; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; CARCINOMA IN SITU; DISSECTION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; STOMACH NEOPLASMS; STOMACH ULCER; WOUND HEALING;

EID: 84857651858     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2011.01178.x     Document Type: Article

References (34)

1. Treiber G, Lambert JR,. The impact of Helicobacter pylori eradication on peptic ulcer healing. Am. J. Gastroenterol. 1998; 93: 1080-4. (Pubitemid 29080954)
2. Arkkila PE, Seppala K, Kosunen TU, et al,. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am. J. Gastroenterol. 2003; 98: 2149-56. (Pubitemid 37305351)
3. Malfertheiner P, Kirchner T, Kist M, et al,. Helicobacter pylori eradication and gastric ulcer healing-comparison of three pantoprazole-based triple therapies. Aliment. Pharmacol. Ther. 2003; 17: 1125-35. (Pubitemid 36605749)
4. Marshall BJ, Warren JR,. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-15.
5. Malfertheiner P, Chan FK, McColl KE,. Peptic ulcer disease. Lancet 2009; 374: 1449-61.
6. Ramakrishnan K, Salinas RC,. Peptic ulcer disease. Am. Fam. Physician. 2007; 76: 1005-12.
7. Leung WK, Wu MS, Kakugawa Y, et al,. Screening for gastric cancer in Asia: Current evidence and practice. Lancet Oncol. 2008; 9: 279-87. (Pubitemid 351722947)
8. Yoshida S, Kozu T, Gotoda T, et al,. Detection and treatment of early cancer in high-risk populations. Best Pract. Res. Clin. Gastroenterol. 2006; 20: 745-65. (Pubitemid 44391327)
9. Uedo N, Takeuchi Y, Yamada T, et al,. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: A prospective randomized controlled trial. Am. J. Gastroenterol. 2007; 102: 1610-16. (Pubitemid 47206669)
10. Takizawa K, Oda I, Gotoda T, et al,. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-an analysis of risk factors. Endoscopy 2008; 40: 179-83. (Pubitemid 351404659)
11. Kakushima N, Yahagi N, Fujishiro M, et al,. The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig. Endosc. 2004; 16: 327-31. (Pubitemid 39421399)
12. Kakushima N, Fujishiro M, Yahagi N, et al,. Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection. J. Gastroenterol. Hepatol. 2006; 21: 1586-9. (Pubitemid 44266519)
13. Lee SY, Kim JJ, Lee JH, et al,. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest. Endosc. 2004; 60: 213-7. (Pubitemid 38980671)
14. Oda I, Gotoda T, Hamanaka H, et al,. Endoscopic submucosal dissection for early gastric cancer: Technical feasibility, operation time and complications from a large consecutive series. Dig. Endosc. 2005; 17: 54-8. (Pubitemid 40313081)
15. Okano A, Hajiro K, Takakuwa H, et al,. Predictors of bleeding after endoscopic mucosal resection of gastric tumors. Gastrointest. Endosc. 2003; 57: 687-90.
16. Goto O, Fujishiro M, Kodashima S, et al,. A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: A retrospective analysis of postendoscopic submucosal dissection bleeding. Gastrointest. Endosc. 2010; 71: 241-8.
17. Gotoda T, Yanagisawa A, Sasako M, et al,. Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two large centers. Gastric. Cancer 2000; 3: 219-25. (Pubitemid 32290729)
18. Huang JQ, Sridhar S, Hunt RH,. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis. Lancet 2002; 359: 14-22. (Pubitemid 34119190)
19. Sakamoto C, Sugano K, Ota S, et al,. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur. J. Clin. Pharmacol. 2006; 62: 765-72. (Pubitemid 44289508)
20. Messer J, Reitman D, Sacks HS, et al,. Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N. Engl. J. Med. 1983; 309: 21-4. (Pubitemid 13062890)
21. Kakushima N, Fujishiro M, Kodashima S, et al,. Learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms. Endoscopy 2006; 38: 991-5. (Pubitemid 44615234)
22. Ono H, Kondo H, Gotoda T, et al,. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48: 225-9. (Pubitemid 32141848)
23. Fujishiro M, Kodashima S, Goto O, et al,. Technical feasibility of endoscopic submucosal dissection of gastrointestinal epithelial neoplasms with a splash-needle. Surg. Laparosc. Endosc. Percutan. Tech. 2008; 18: 592-7.
24. Yamamoto H, Kawata H, Sunada K, et al,. Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate. Gastrointest. Endosc. 2002; 56: 507-12.
25. Sakita T, Fukutomi H,. Endoscopic diagnosis. In:, Yoshitoshi Y, (ed.). Ulcer of the Stomach and Duodenum. Tokyo: Nankodo, 1971; 198-208. (in Japanese)
26. Vakil N, Fennerty MB,. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment. Pharmacol. Ther. 2003; 18: 559-68. (Pubitemid 37186605)
27. Kakushima N, Fujishiro M, Kodashima S, et al,. Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy 2006; 38: 412-5.
28. Hashimoto T, Adachi K,. Changes in gastric mucosal blood flow during healing of EMR-induced ulcer-comparison with peptic ulcer. Dig. Endosc. 1997; 9: 127-31. (Pubitemid 27226568)
29. Tarnawski A, Stachura J, Durbin T, et al,. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992; 102: 695-8.
30. Shay H, Sunn DCH,. Etiology and pathology of gastric and duodenal ulcer. In:, Bockus HL, (ed.). Gastroenterology, 2nd edn. Philadelphia & London: WB Saunders, 1996; 420-65.
31. Mannen K, Tsunada S, Hara M, et al,. Risk factors for complications of endoscopic submucosal dissection in gastric tumors: Analysis of 478 lesions. J. Gastroenterol. 2010; 45: 30-6.
32. Oi M, Ito Y, Kumagai F, et al,. A possible dual control mechanism in the origin of peptic ulcer. A study on ulcer location as affected by mucosa and musculature. Gastroenterology 1969; 57: 280-93.
33. Fukase K, Kato M, Kikuchi S, et al,. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 2008; 372: 392-7.
34. Ono S, Fujishiro M, Niimi K, et al,. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig. Liver Dis. 2009; 41: 725-8.